Back to search

Pierian Biosciences Limited

09716938

active
ltd
england wales
Companies House
Health Score
65 / 100

Some Concerns

25/30
Filing
0/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)

Details

101 New Cavendish Street, 1st Floor South, London, W1W 6XH
Incorporated 04/08/2015

Previously known as

Diatech Oncology Limited · until 07/03/2022

Compliance

Last accounts

31/12/2024

small

Next accounts due

25/09/2026

On track

Confirmation statement

Last: 31/12/2025

Due 14/01/2027

On track

Industry

74909
Other professional, scientific and technical activities

Officers

Mr Andrew Woodfin Miller Jr

director · Since 04/08/2015

BUSINESS EXECUTIVE

AMERICAN · UNITED STATES · Age 62

Also on 1 other board

Mr Robert Edward Henry

director · Since 04/08/2015

BUSINESS EXECUTIVE

AMERICAN · UNITED STATES · Age 67

Mr Laurence John Cohen

director · Since 10/11/2015

LAWYER

BRITISH · ENGLAND · Age 74

Also on 10 other boards

Mr James Carl Siti

director · Since 16/01/2017

PHARMACEUTICAL CONSULTANT

AMERICAN · UNITED STATES · Age 55

Robert Edward Henry

director · Since 04/08/2015

American · United States · Age 67

Andrew Woodfin Miller Jr

director · Since 04/08/2015

American · United States · Age 62

Laurence John Cohen

director · Since 10/11/2015

British · England · Age 74

James Carl Siti

director · Since 16/01/2017

American · United States · Age 55

Former

Ian Rudolf Ferrier

director · Resigned 01/11/2016

Mark Stephen Gelder

director · Resigned 31/10/2017

John Paul Anthony Crown

director · Resigned 23/04/2018

Anna Obolensky

director · Resigned 23/05/2019

Persons with Significant Control

Pierian Holdings, Inc.

75–100% shares
75–100% votes
Appoint directors

479 Sam Ridley Parkway, Suite 105 Pmb 292, Smyrna

Reg: 5808500 · Delaware · Corporation

Notified 06/04/2016

Change History

statusactive
2026-07-17

Active

typeltd
2026-07-17

Private Limited Company

address line1101 New Cavendish Street
2026-07-17

101 NEW CAVENDISH STREET

post townLondon
2026-07-17

LONDON

CompanyRankvs 30803+ SIC 74909 peers
56

Financial strength0th percentile among SIC peers · 0/25
Employees94th percentile among SIC peers · 14/15
LiquidityCurrent ratio 1.93× · 16/20
Longevity11 years trading (max 15) · 11/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity11/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

-£2.8M

Balance sheet strength

Cash

£16k

Cash in the bank

Net Current Assets

£57k

Working capital

Current Assets

£119k

Current Liabilities

£61k

Fixed Assets

£695k

Debtors

£102k

6avg. employees+1

People Costs

Wages & salaries£492k

Balance Sheet

Assets less current liabilities£752k
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20241.93-£1.0M
20231.45

Derived from filed accounts. Not audited figures.